The largest database of trusted experimental protocols

5 protocols using pe anti mouse ifn γ clone xmg1

1

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions were pretreated with mouse Fc-Block™ (BD Biosciences/ Pharmingen) and incubated with fluorophore-labeled antibodies or appropriate isotype controls. Acquisitions were performed using a BD FACSCanto™ II (BD Bioscience). For intracellular staining of cytokines BD Cytofix/Cytoperm (BD Biosciences) was used. Analysis was done using BD FACSDiva™ and FlowJo (Treestar INC.) software. Following antibodies were used: Phycoerythrin-(PE), allophycocyanin-(APC) and PE/Cy7 anti-human FcεRIα mAb CRA1 (clone AER-37, eBioscience or BioLegend), PE-anti-mouse IgE (RME-1, Biolegend), APC-anti-CD11c, Alexa Fluor® 647 anti-mouse CD8α and Alexa Fluor® 647 anti-mouse CD4 from Biolegend (San Diego, CA), PE-anti-mouse CD86 (BD Pharmingen), APC-anti- CD117 (Biolegend), and PE- anti-mouse FcεRIα mAb (Mar1, Biolegend). Intracellular cytokine stain included PE anti-mouse IFN-γ (clone XMG1.2, Biolegend) and APC anti-mouse IL-4 (clone 11B11, eBioscience). Anti-human CD1c (BDCA-1, clone AD5-8E7, Miltenyi Biotech), APC-anti-human CD19 (clone HIB19, BioLegend), PE/Cy7 anti- human IgE (clone MHE-18, BioLegend), PE anti-human CD203 (Biolegend), Alexa Fluor® anti human CD83 (clone HB15e), PE anti-human CD80 (Biolegend) and APC anti-human CD1a (BD Pharmingen).
+ Open protocol
+ Expand
2

Cytokine Profiling of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions were prepared from spleens. 1 x 106 cells were cocultured in round bottom 96 well plates with 1 μg/ml H-2Ld IE peptide YPHFMPTNL or, as negative control, scrambled peptide NFYPTLPHM for 1 h. After that, Brefeldin A (Biolegend) was added at a concentration of 5 μg/ml and the coculture continued for 5 h. Cells were stained for CD8 (FITC anti-mouse CD8a, clone 53–6.7; Biolegend), fixed in 1% paraformaldehyde, permeabilized with 0.1% saponin (Sigma-Aldrich), stained for intracytoplasmic IFN-γ (PE anti-mouse IFN-γ, clone XMG1.2; Biolegend), analyzed on a FACSCalibur and depicted using FlowJo software (BD Biosciences).
+ Open protocol
+ Expand
3

OT-I Memory CD8+ T Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes from OT-I mice were obtained aseptically. Cells were cultured in 96-well plate (105 cells/well) and activated with SIINFEKL peptide (4 × 10−9 M) in the presence or absence of SCFAs (400 μM) for 3 days. Then cells were washed 3 times with T cell medium and further cultured with interleukin-15 (IL-15, 10 ng/mL, from PeproTech, Rocky Hill, NJ) in the presence or absence of SCFAs for 3 days to generate of OVA-specific OT-I memory CD8+ T cells. Thereafter, cells were washed twice and re-activated with SIINFEKL peptide (10 μM) for 2 h. Subsequently, brefeldin A was added (1 : 1000 dilution) and incubated for another 2 h. The suspension cells were collected, blocked with CD16/32 antibody, and stained with fixable viability dye eFluor™ 450, FITC-CD44 Rat anti-Human/Mouse, PE-Cy7-CD62L Monoclonal Antibody. Intracellular IFN-γ (PE-anti-mouse IFN-γ, clone: XMG1.2, Biolegend) and Tcf1 (PE-Tcf1/Tcf7 Rabbit mAb) positive T cells were detected via flow cytometry.
+ Open protocol
+ Expand
4

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions were pretreated with mouse Fc-Block™ (BD Biosciences/ Pharmingen) and incubated with fluorophore-labeled antibodies or appropriate isotype controls. Acquisitions were performed using a BD FACSCanto™ II (BD Bioscience). For intracellular staining of cytokines BD Cytofix/Cytoperm (BD Biosciences) was used. Analysis was done using BD FACSDiva™ and FlowJo (Treestar INC.) software. Following antibodies were used: Phycoerythrin-(PE), allophycocyanin-(APC) and PE/Cy7 anti-human FcεRIα mAb CRA1 (clone AER-37, eBioscience or BioLegend), PE-anti-mouse IgE (RME-1, Biolegend), APC-anti-CD11c, Alexa Fluor® 647 anti-mouse CD8α and Alexa Fluor® 647 anti-mouse CD4 from Biolegend (San Diego, CA), PE-anti-mouse CD86 (BD Pharmingen), APC-anti- CD117 (Biolegend), and PE- anti-mouse FcεRIα mAb (Mar1, Biolegend). Intracellular cytokine stain included PE anti-mouse IFN-γ (clone XMG1.2, Biolegend) and APC anti-mouse IL-4 (clone 11B11, eBioscience). Anti-human CD1c (BDCA-1, clone AD5-8E7, Miltenyi Biotech), APC-anti-human CD19 (clone HIB19, BioLegend), PE/Cy7 anti- human IgE (clone MHE-18, BioLegend), PE anti-human CD203 (Biolegend), Alexa Fluor® anti human CD83 (clone HB15e), PE anti-human CD80 (Biolegend) and APC anti-human CD1a (BD Pharmingen).
+ Open protocol
+ Expand
5

OT-I Memory CD8+ T Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes from OT-I mice were obtained aseptically. Cells were cultured in 96-well plate (105 cells/well) and activated with SIINFEKL peptide (4 × 10−9 M) in the presence or absence of SCFAs (400 μM) for 3 days. Then cells were washed 3 times with T cell medium and further cultured with interleukin-15 (IL-15, 10 ng/mL, from PeproTech, Rocky Hill, NJ) in the presence or absence of SCFAs for 3 days to generate of OVA-specific OT-I memory CD8+ T cells. Thereafter, cells were washed twice and re-activated with SIINFEKL peptide (10 μM) for 2 h. Subsequently, brefeldin A was added (1 : 1000 dilution) and incubated for another 2 h. The suspension cells were collected, blocked with CD16/32 antibody, and stained with fixable viability dye eFluor™ 450, FITC-CD44 Rat anti-Human/Mouse, PE-Cy7-CD62L Monoclonal Antibody. Intracellular IFN-γ (PE-anti-mouse IFN-γ, clone: XMG1.2, Biolegend) and Tcf1 (PE-Tcf1/Tcf7 Rabbit mAb) positive T cells were detected via flow cytometry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!